Purchase Order 75N93023P01328
Award Date 9/18/23
Potential Completion Date 9/17/24
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. National Institutes of Health (NIH) awarded a $21,230.00 firm fixed price purchase order to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services. The contract is for Mission Bio's Tapestri Single Cell DNA and Protein Kit, which supports NIH's biomedical research and genomics efforts in areas like infectious disease, hematology, oncology, and personalized medicine. Mission Bio is a registered federal contractor that has previously received NIH...
- This is a $22,755 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services based in South San Francisco, California. The contract is for the provision of Mission Bio's Tapestri Single-Cell DNA and Protein Reagent Kits, sequencing instruments, and genomic analysis services to support critical biomedical research efforts in areas such as infectious disease,...
- This is a $22,755 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services based in South San Francisco, California. The contract is for the provision of Mission Bio's Tapestri Single-Cell DNA and Protein Reagent Kits, sequencing instruments, and genomic analysis services to support critical biomedical research efforts in areas such as infectious...
- The National Institutes of Health (NIH) Clinical Center awarded a $22.8K purchase order to Mission Bio, Inc. on August 26, 2025, for the delivery of Mission Bio Reagent Kits. This firm fixed-price contract, which carries no set-aside designation, is scheduled for completion by August 25, 2026, with performance taking place at Mission Bio's facility in South San Francisco, California. The award represents a continuation of the NIH Clinical Center's relationship with Mission Bio, a specialized...
- The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a firm-fixed-price purchase order contract to Mission Bio, Inc., a for-profit manufacturer, to provide a Tapestri Single-Cell DNA Training Kit. The contract has a potential value of $162,150.00 and a completion date of January 19, 2024. This award does not have a small business set-aside designation. Mission Bio is a vendor that has previously received prime federal contract awards and...
- This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) to Mission Bio, Inc., a for-profit manufacturer of biological supplies, reagent kits, sequencing instruments, and sequencing services. The $21,230 contract supports NIH's biomedical research and genomics efforts in areas such as infectious disease, hematology, oncology, and personalized medicine. Mission Bio has also received a $1.8 million National Cancer Institute grant to support measurable residual...
- <p>The NIH Clinical Center awarded a purchase order to Mission Bio, Inc. for $21,380.00 on May 28, 2026, for Tapestri Single-Cell DNA + Protein Reagent Kit V3 and Tapestri Single-Cell DNA Cartridge Kit V3. No set-aside applies. Work is performed in South San Francisco, California. The order is firm fixed price with an ultimate completion date of November 27, 2026.</p>
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Mission Bio, Inc. for Tapestri Single-Cell Kits valued at $26,400 on September 18, 2018. Work is performed in South San Francisco, California. The order covers single-cell DNA and protein sequencing reagent kits supporting biomedical research. Ultimate completion is November 30, 2018. The procurement was issued under a special notice without a small business set-aside.</p>
- The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $34,966 firm fixed-price purchase order to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services. The contract is for the delivery of Tapestri Single-Cell DNA + Protein Reagent Kits to support NHLBI's biomedical research and genomics efforts. The contract has a performance period through December 19, 2025 and does not utilize any...
- The federal contract award is a firm fixed-price purchase order valued at $138,625 issued by the National Institutes of Health National Institute on Aging to Mission Bio, Inc. for the delivery of a Tapestri Multiome Sequencing Instrument. The instrument will support the agency's research efforts to sequence multiple types of biological data from a single sample. The contract has a period of performance from June 20th, 2023 through September 20th, 2023 with delivery to occur within 30 days of...
Mission Bio, Inc. was awarded an $11,130 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to deliver a Mission Bio Tapestry single-cell DNA 4 sample proof of principle kit (version 3). The purchase order has a period of performance of just under one year, running from September 2023 through September 2024. Place of performance will be Mission Bio's facilities in South San Francisco, California. No subcontractors or set aside designations were identified. This purchase supports early feasibility testing of Mission Bio's Tapestry single-cell genomics platform to advance NIH's biomedical research efforts in understanding disease at the single cell level.
Generated 12/16/23, 9:27 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 9/18/23 |